enGene Holdings Inc. ( ENGN) - Key Metrics
ENGN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0 | $0.47 | -$0.27 | -$0.27 |
| 2026Q2 | $0 | $0.43 | -$0.44 | -$0.44 |
| 2026Q1 | $0 | -$0.44 | -$0.43 | -$0.43 |
| 2025Q4 | $0 | -$0.74 | -$0.49 | -$0.50 |
| 2025Q3 | $0 | -$0.57 | -$0.50 | -$0.52 |
ENGN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | 0.95 |
| 2026Q2 | 0% | 4.23 |
| 2026Q1 | 0% | -5.41 |
| 2025Q4 | 0% | -2.44 |
| 2025Q3 | 0% | -1.66 |
ENGN
Price: $1.71
52 week price:
Earnings Per Share: -2.07 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 130.0 million